mary rozenman  aimmune therapeutics inc  zoominfocom﻿ insider selling aimmune therapeutics inc aimt insider sells  shares of stock  bnb daily daily ratings  news for aimmune therapeutics inc complete the form below to receive the latest headlines and analysts recommendationsfor aimmune therapeutics inc with our free daily email newsletter follow bnbdailynews recent posts hightower advisors llc purchases  shares of rogers corporation rog nuveen asset management llc has  million stake in aaron’s inc nyseaan cf industries holdings inc cf shares bought by nomura asset management co ltd nomura asset management co ltd sells  shares of avery dennison corporation avy dnb asset management as has  stake in unum group unm kames capital plc holds position in t rowe price group inc trow fisher asset management llc raises stake in biorad laboratories inc bio atria investments llc sells  shares of camden property trust cpt exxonmobil investment management inc tx has  million position in red hat inc rht fisher asset management llc boosts position in cemex sab de cv cx fisher asset management llc decreases position in umpqua holdings corporation umpq livforsakringsbolaget skandia omsesidigt has  stake in dollar tree inc dltr macerich company the mac position raised by xact kapitalforvaltning ab xact kapitalforvaltning ab boosts position in bunge limited bg positive press coverage somewhat unlikely to affect transcanada corporation nysetrp share price telecom argentina stet – france telecom nyseteo getting somewhat favorable media coverage study finds tier reit otcmktstier earns daily news sentiment rating of  trinity biotech plc trib given media impact score of  landec corporation lndc earns daily coverage optimism score of  insider selling aimmune therapeutics inc aimt insider sells  shares of stock insider selling aimmune therapeutics inc aimt insider sells  shares of stock posted by dan jones on jul th   no comments aimmune therapeutics inc nasdaqaimt insider mary m rozenman sold  shares of the business’s stock in a transaction that occurred on wednesday july th the shares were sold at an average price of  for a total value of  following the completion of the sale the insider now owns  shares in the company valued at approximately  the transaction was disclosed in a legal filing with the sec which is accessible through this link shares of aimmune therapeutics inc aimt opened at  on tuesday aimmune therapeutics inc has a one year low of  and a one year high of  the company’s day moving average price is  and its day moving average price is  the company’s market capitalization is  billion get aimmune therapeutics inc alerts aimmune therapeutics nasdaqaimt last posted its quarterly earnings results on monday may th the biotechnology company reported  earnings per share for the quarter topping the consensus estimate of  by  on average equities research analysts predict that aimmune therapeutics inc will post  earnings per share for the current year copyright violation notice this article was first reported by bnb daily and is owned by of bnb daily if you are reading this article on another site it was illegally stolen and reposted in violation of us and international copyright legislation the original version of this article can be viewed at httpswwwbaseballnewsblogcomaimmunetherapeuticsincaimtinsidermarymrozenmansellssharesofstockupdatedupdatedhtml a number of research analysts recently weighed in on aimt shares zacks investment research raised aimmune therapeutics from a “sell” rating to a “buy” rating and set a  target price on the stock in a report on tuesday may th valuengine raised aimmune therapeutics from a “sell” rating to a “hold” rating in a report on tuesday june th finally wedbush reaffirmed an “outperform” rating and issued a  price objective on shares of aimmune therapeutics in a report on monday two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock aimmune therapeutics currently has an average rating of “buy” and an average price target of  a number of institutional investors have recently added to or reduced their stakes in aimt franklin street advisors inc nc acquired a new position in aimmune therapeutics during the first quarter valued at about  state street corp boosted its position in aimmune therapeutics by  in the fourth quarter state street corp now owns  shares of the biotechnology company’s stock valued at  after buying an additional  shares during the period russell investments group ltd acquired a new position in aimmune therapeutics during the fourth quarter valued at about  renaissance technologies llc acquired a new position in aimmune therapeutics during the fourth quarter valued at about  finally palo alto investors llc boosted its position in aimmune therapeutics by  in the first quarter palo alto investors llc now owns  shares of the biotechnology company’s stock valued at  after buying an additional  shares during the period  of the stock is currently owned by institutional investors and hedge funds about aimmune therapeutics aimmune therapeutics inc is a clinicalstage biopharmaceutical company developing a therapeutic approach including the development of product candidates for the treatment of peanut and other food allergies the company’s therapeutic approach which it refers to as characterized oral desensitization immunotherapy codit is a system designed to desensitize patients to food allergens using characterized biologic products defined treatment protocols and support services receive news  ratings for aimmune therapeutics inc daily  enter your email address below to receive a concise daily summary of the latest news and analysts ratings for aimmune therapeutics inc and related companies with marketbeatcoms free daily email newsletter latest news leave a reply click here to cancel reply name required mail will not be published required website ﻿ mary m rozenman sells  shares of aimmune therapeutics inc aimt stock  chaffey breeze daily ratings  news for aimmune therapeutics inc complete the form below to receive the latest headlines and analysts recommendationsfor aimmune therapeutics inc with our free daily email newsletter follow chaffeybreeze recent posts hancock holding company nasdaqhbhc stake cut by bank of america corp de store capital corporation nysestor shares sold by bank of america corp de weiss multi strategy advisers llc cuts position in the charles schwab corporation schw vertex pharmaceuticals incorporated vrtx to post q  earnings of  per share leerink swann forecasts cabela’s inc cab shares bought by schwab charles investment management inc national instruments corporation nati shares bought by schwab charles investment management inc q  eps estimates for pinnacle west capital corporation nysepnw lifted by analyst community bank system inc cbu shares sold by amalgamated bank amalgamated bank acquires  shares of drilquip inc drq stanley black  decker’s swk “equal weight” rating reaffirmed at morgan stanley q  earnings forecast for usg corporation usg issued by suntrust banks renaissance technologies llc has  million stake in sigma designs inc sigm ceva inc nasdaqceva shares sold by new york state teachers retirement system pbf energy inc nysepbf stake decreased by morgan stanley ubs ag reiterates buy rating for o’reilly automotive inc orly  earnings per share expected for intuitive surgical inc nasdaqisrg this quarter o’reilly automotive inc orly stock rating reaffirmed by oppenheimer holdings inc northland securities reaffirms “buy” rating for starcom plc star photome international plc phtm rating reiterated by finncap finncap reiterates corporate rating for zoo digital group plc zoo mary m rozenman sells  shares of aimmune therapeutics inc aimt stock posted by chloe mcguire on jul th   no comments aimmune therapeutics inc nasdaqaimt insider mary m rozenman sold  shares of the company’s stock in a transaction dated monday july th the stock was sold at an average price of  for a total transaction of  following the completion of the sale the insider now directly owns  shares of the company’s stock valued at  the sale was disclosed in a filing with the sec which is accessible through this link shares of aimmune therapeutics inc aimt opened at  on wednesday the firm has a day moving average of  and a day moving average of  the company’s market capitalization is  billion aimmune therapeutics inc has a  month low of  and a  month high of  get aimmune therapeutics inc alerts aimmune therapeutics nasdaqaimt last issued its earnings results on monday may th the biotechnology company reported  earnings per share eps for the quarter topping the consensus estimate of  by  on average equities analysts predict that aimmune therapeutics inc will post  earnings per share for the current year copyright violation warning “mary m rozenman sells  shares of aimmune therapeutics inc aimt stock” was posted by chaffey breeze and is owned by of chaffey breeze if you are viewing this report on another site it was illegally copied and republished in violation of united states and international copyright  trademark legislation the correct version of this report can be read at httpswwwchaffeybreezecommarymrozenmansellssharesofaimmunetherapeuticsincaimtstockhtml a number of brokerages have issued reports on aimt piper jaffray companies reaffirmed an “overweight” rating and issued a  price objective on shares of aimmune therapeutics in a research report on wednesday march nd zacks investment research downgraded shares of aimmune therapeutics from a “buy” rating to a “hold” rating in a research report on tuesday july th finally valuengine raised shares of aimmune therapeutics from a “sell” rating to a “hold” rating in a research report on tuesday june th two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock the stock currently has a consensus rating of “buy” and an average target price of  hedge funds and other institutional investors have recently modified their holdings of the company victory capital management inc purchased a new position in shares of aimmune therapeutics during the first quarter valued at about  swiss national bank boosted its position in shares of aimmune therapeutics by  in the first quarter swiss national bank now owns  shares of the biotechnology company’s stock valued at  after buying an additional  shares during the period zurcher kantonalbank zurich cantonalbank boosted its position in shares of aimmune therapeutics by  in the first quarter zurcher kantonalbank zurich cantonalbank now owns  shares of the biotechnology company’s stock valued at  after buying an additional  shares during the period c worldwide group holding a s purchased a new position in shares of aimmune therapeutics during the first quarter valued at about  finally nationwide fund advisors boosted its position in shares of aimmune therapeutics by  in the first quarter nationwide fund advisors now owns  shares of the biotechnology company’s stock valued at  after buying an additional  shares during the period  of the stock is owned by institutional investors and hedge funds aimmune therapeutics company profile aimmune therapeutics inc is a clinicalstage biopharmaceutical company developing a therapeutic approach including the development of product candidates for the treatment of peanut and other food allergies the company’s therapeutic approach which it refers to as characterized oral desensitization immunotherapy codit is a system designed to desensitize patients to food allergens using characterized biologic products defined treatment protocols and support services receive news  ratings for aimmune therapeutics inc daily  enter your email address below to receive a concise daily summary of the latest news and analysts ratings for aimmune therapeutics inc and related companies with marketbeatcoms free daily email newsletter latest news leave a reply click here to cancel reply name required mail will not be published required website rozenman mary m  insider stock trading  openinsider sector all sectors group by sector aerospace agriculture automobile building business services chemical electrical energy fashion financial food  beverage fund healthcare household insurance machinery media metals mining other personal services real estate retail technology telecom transportation utility industry all industries group by industry insiders filings all purchases sales cik   address aimmune therapeutics inc  marina boulevard suite  brisbane ca   results links secyahoogooglefinviztradingviewstockchartsstocktwitsdownload csv tc stat stk ins fil d w m q h y avg sretswins filing date t date ticker issuerinc sector indindustry owner ost rel title t tval price l qty oc own h ry ry rm rm rw rw rd rd fd fw fm fm fm fy  aimtaimmune therapeutics inchealthdrugpharmaceutical preparationsrozenman mary mcaosee remamdmd  aimtaimmune therapeutics inchealthdrugpharmaceutical preparationsrozenman mary mcaosee remasdmd  aimtaimmune therapeutics inchealthdrugpharmaceutical preparationsrozenman mary mcaosee remamdmd  aimtaimmune therapeutics inchealthdrugpharmaceutical preparationsrozenman mary mcaosee remasdmd  aimtaimmune therapeutics inchealthdrugpharmaceutical preparationsrozenman mary mcaosee remamdd  aimtaimmune therapeutics inchealthdrugpharmaceutical preparationsrozenman mary mcaosee remasdd  aimtaimmune therapeutics inchealthdrugpharmaceutical preparationsrozenman mary mcaosee remamdd  aimtaimmune therapeutics inchealthdrugpharmaceutical preparationsrozenman mary mcaosee remasdd  aimtaimmune therapeutics inchealthdrugpharmaceutical preparationsrozenman mary mcaosee remamdd  aimtaimmune therapeutics inchealthdrugpharmaceutical preparationsrozenman mary mcaosee remasdd dderivative transaction in filing usually option exercise mmultiple transactions in filing earliest reported transaction date and weighted average transaction price aamended filing eerror detected in filing s  salesale of securities on an exchange or to another person s  saleoesale of securities on an exchange or to another person after option exercise f  taxpayment of exercise price or tax liability using portion of securities received from the company p  purchasepurchase of securities on an exchange or from another person return to top contact copyright   openinsidercom all rights reserved mary m rozenman  new york ny  intelius sign in we found mary m rozenman in new york ny mary m rozenman intelius found that mary m rozenman is a female between  and  years old from new york ny we have connected them to  addresses  phones and  relatives or associates get report now age mary m rozenman is in her s mary has lived in new york ny san mateo ca san francisco ca mary m rozenman zodiac signaquarius genderfemale professional status vice president at longitude capital get report now want to know more about mary get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about mary or use our people search engine to find others get background check on mary m rozenman get a criminal check on mary m rozenman get a public record report on mary m rozenman get a people search report on mary m rozenman mary m rozenmans contact information known cities lived in find out where mary m rozenman has lived as well as mary m rozenmans phone numbers and email addresses mary m rozenman has lived in  states new york address for mary m rozenman  e  s new york ny has lived in new york ny san mateo ca get full address report phone numbers associated with mary m rozenman    new york ny    new york ny    menlo park ca get full phone report email addresses associated with mary m rozenman mnnet mnnet mncom get email report mary m rozenmans professional information information regarding mary m rozenmans professional history find out previous places mary m rozenman has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act mary m rozenman has worked at  places company longitude capital title vice president company allergen nce inc title senior vice president corporate commercial development mary m rozenmans experience title vice president company longitude capital job details company size less than  mil  employee range less than  longitude capital is a private investment firm that focuses on venture growth investments in drug development and medical technology founded in  longitude capital operates bicoastally with offices in menlo park ca and greenwich ct  longitude capital has over  million in assets under management and most recently raised  million for its second fund longitude venture partners ii lp in  title senior vice president corporate commercial development company allergen nce inc job details company size less than  mil additional professional information on mary m rozenman see mary m rozenmans linkedin profile mary m rozenmans social network and potential email matches find out potential social network profiles and potential email usernamed for mary m rozenman mary m rozenmans known social networks and potential email matches find all of mary m rozenmans social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches mary rozenman username matches maryrozenman rozenmanmary maryrozenman rozenmanmary maryrozenman rozenmanmary maryrozenman rozenmanmary mrozenman popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches m rozenman intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here aimt mary m rozenman insider trades for aimmune therapeutics inc bulletin tobacco stocks crushed by fda announcement » fda unveils plan to lower cigarette nicotine content to nonaddictive level » investor alert london markets close in currencies futures metals stocks expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close aimmune therapeutics inc nasdaq aimt go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus aimmune therapeutics inc market open  real time quotes jul    am aimt quoteszigmancomposite   change   volume volume  real time quotes quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual mary m rozenman dr mary m rozenman is vice president at longitude capital management co llc she focuses on investments in biotechnology prior to joining longitude capital in  dr rozenman was an associate principal at mckinsey  company and a leader in the healthcare and corporate finance practices at mckinsey dr rozenman served clients across the biotechnology and medical technology industries on a variety of strategic and operational initiatives across commercial operations research clinical and corporate development dr rozenman also led the support of over  billion in healthcare transactions for mckinseys leading private equity clients dr rozenman holds a phd in organic chemistry and chemical biology from harvard university she also holds a ba in russian literature and biochemistry from columbia college where she was a john jay scholar transactions date shares transaction value     disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share           disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives dr stephen george dilly president chief executive officer  director mr jeffrey h knapp chief operating officer mr eric h bjerkholt chief financial officer ms annette marcantonio vice presidentclinical operations dr daniel c adelman chief medical officer dr mary m rozenman senior vpcorporate development  strategy ms susan e barrowcliffe general managereurope  senior vice president ms levan nguyen vice presidentus regulatory affairs mr gregory behar director dr laura g hansen vice presidentinvestor relations mr kenneth f boehm vice presidenthuman resources mr douglas t sheehy secretary  general counsel mr william turner svpglobal regulatory affairs  quality assurance mr mark d mcdade chairman mr mark t iwicki independent director ms kathryn e falberg independent director ms stacey denenberg seltzer independent director mr patrick g enright independent nonemployee director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york open marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest ainvisalign maker align stocks surge  after earnings blow past estimates adow trades flat at  sp  off  at  anasdaq off  at  abreakingdow briefly turns positive as stock market pares opening loss ajapan slaps  tariff on us frozen beef first such action in  years apacking the pounds back on pigs abreakingfda says it plans to lower nicotine in cigarettes to nonaddictive levels adollar turns lower for the week following gdp report aset yourself up to get the most out of retirement atesla earnings will model  live up to the hype abitcoin prices rise as ether extends recent weakness atreasury yields dip after secondquarter gdp data anew rule forces big car makers into big changes in how they count revenues athese are the times you’re actually allowed to put money back into your ira aweekend sip is this the world’s first distilled nonalcoholic spirit aus gdp speeds up to  in nd quarter atime for gop to face reality everybody is going to have health insurance astock market edges lower on track for weekly losses ahoward marks says bitcoin isn’t real—and we can all blame millennials for its rise aminor lift for final consumer sentiment reading in july as partisan divide remains loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft mary m rozenman  publications log in sign up log in to add people  connections or click here to create an account save login  forgot password already have an account log in herelogin idpasswordreenteremaildont worry your email will not be distributed or made public its only purpose is for us to contact you about your account close login sign up ☰ chemistry tree treerecent additionsdistanceanalysishelpreport bugsign inregister mary m rozenman phd  publications affiliations  harvard university cambridge ma united states  area the chemistry of molecular evolution tree info pubmed report error  highprobability publications we are testing a new system for linking publications to authors you can help if you notice any innacuracies please sign in and mark papers as correct or incorrect matches if you identify any major omissions or other inaccuracies in the publication list please let us know year citation  score  rozenman mm kanan mw liu dr development and initial application of a hybridizationindependent dnaencoded reaction discovery system compatible with organic solvents journal of the american chemical society   pmid  doi jaj    rozenman mm mcnaughton br liu dr solving chemical problems through the application of evolutionary principles current opinion in chemical biology   pmid  doi jcbpa    rozenman mm liu dr dnatemplated synthesis in organic solvents chembiochem  a european journal of chemical biology   pmid  doi cbic    kanan mw rozenman mm sakurai k snyder tm liu dr reaction discovery enabled by dnatemplated synthesis and in vitro selection nature   pmid  doi nature   show lowprobability matches see remarks of aimmune therapeutics nasdaqaimt rozenman mary m sells  shares worth  stay connected latest posts in rss businessentertainmentfeatured newsfeatured press releasefinancehealthlifestylenationnon firstpageoriginalpress releasereviewshoppingsportsstockstechnologytravelworld latest comments in rss  empowerednews world news summary helping you stay informed business finance sports entertainment health technology travel shopping our writers about us privacy policy contact us advertise press releases see remarks of aimmune therapeutics nasdaqaimt rozenman mary m sells  shares worth  according to aimmune therapeuticss most recent form  filing with the sec dated jul   pm company see remarks rozenman mary m disclosed selling  shares at a cost of  at the time of this transaction jul  this trade was worth  in total as of jul  rozenman mary m now owns  shares in total worth about  for the last few recent trades made by aimmune therapeutics nasdaqaimt see remarks rozenman mary m we have the following information sec form  filing jul  sold  shares at the rate of  per share total worth of this trade was  total number of shares owned as of jul  were  sec form  filing nov  sold  shares at the rate of  per share total worth of this trade was  total number of shares owned as of nov  were  sec form  filing oct  sold  shares at the rate of  per share total worth of this trade was  total number of shares owned as of oct  were  posted by george daniels on thursday july    pm edt all trademarks acknowledged filed under stocks comments and trackbacks closed follow responses rss  comments are closed latest news president  ceo of sarepta therapeutics nasdaqsrpt ingram douglas s buys  shares worth  director of northwest bancshares nasdaqnwbi tredway philip m sells  shares worth  president of county bancorp nasdaqicbk schneider timothy j sells  shares worth  ceo  chairman of opko health nasdaqopk frost phillip md et al buys  shares worth  director of bryn mawr bank corporation nasdaqbmtc gilbert andrea f sells  shares worth  former  owner of internap corporation nasdaqinap park west asset management llc sells  shares worth  chairman of the board and ceo of salesforce nysecrm benioff marc sells  shares worth  pres sales  cust success of salesforce nysecrm martinez maria sells  shares worth  chief executive officer of salem media group nasdaqsalm atsinger edward g iii sells  shares worth  svp  chief accounting officer of cobiz financial inc nasdaqcobz dumlao troy sells  shares worth  news categories business  stocks  entertainment  featured news  featured press release  finance  health  lifestyle  nation  non firstpage  original  press release  review  shopping  sports  technology  travel  world  featured press releases catheters market growing at steady cagr to  biotechnology market set to register  cagr during  d laser scanners market share growth statistics by application production revenue  forecast to  yoga mat industry overview by manufacturers regions applications types forecast to  particle size analyzers industry overview by manufacturers regions applications types forecast to  body fat measurement market trend to  profiling ge healthcare cosmed and tanita corporation  more global france homeland security  public safety market research report  analysis and forecast to  asiapacific dtv market analysis by key player samsung lg corp sony corp and forecast to  otc drug market trends global industry analysis top manufacturers share growth statistics opportunities  forecast to  new research report inkjet marking coding machines sales market analysis forecast to  business finance sports entertainment health technology travel shopping about us contact us privacy policy advertise press releases terms of service log in rozenman mary m  aimmune therapeutics insider transactions  tipranks go prologin  sign up follow✓get real time transactionsinsider detailsrozenman mary maimmune therapeutics aimtsee remarksranked  out of  insiders on tipranksrozenman mary ms performanceprofitable transactions out of  profitable transactionsaverage returnaverage return per transactioneach transaction is measured over a  year months month period and compared to no benchmarksp sectorhow are insiders ranked most profitable insider tradestock aimmune therapeutics aimttransaction type informative buydates jul    todaygain see the latest stocks traded by insiders  rozenman mary ms trading historybased on form  follow✓get real time transactionscompany nameinsider positionholding valuelast transactionlast transaction amountlast transaction dateaimtaimmune therapeuticssee remarksuninformative selljul  success rate on stock out of  profitable transactions on aimtaverage profit on stockaverage return per transaction on aimt  track record showingall transactionsinformative transactionsdatetransactionamountno of sharesprice per shareprofitform  jul   informative buy k  undisclosed  jul   informative buy k  undisclosed  show moresee all insider trading from today you may also likemeet our smart portfolio see what top analysts say about your stocksget a breakdown of the different strategies based on detected insider trading activityfind the best performing analyst in each sector follow them so you never miss a recommendationrelated linkshow can i benefit from insider trading see the top  corporate insiders go to hot stocks by insiders find which stocks insiders traded today become a tipranks memberget the best investing tips  hacks straight to your emailfree membershipsubmitinsider trading daily newsletterprofessional daytrading strategy based on predictive insider transactionsannual return learn more powered by